What is FEops?
Founded in 2009 and headquartered in Gent, Belgium, FEops is at the forefront of digital health innovation, providing physicians with advanced digital tools designed to optimize the treatment of heart disease patients. By enabling the precise application of the right technology to the right patients at the opportune moment, FEops is fundamentally altering the landscape of cardiovascular care. This strategic financing underscores the company's pivotal role in advancing medical technology and its potential for significant market impact in the digital health sector.
How much funding has FEops raised?
FEops has raised a total of $12M across 3 funding rounds:
Series A
$1.5M
Series B
$7.2M
Debt
$3.3M
Series A (2015): $1.5M with participation from PMVenture and Capricorn Venture Partners
Series B (2017): $7.2M led by PMV, Valiance, and Capricorn Venture Partners
Debt (2022): $3.3M supported by The European Innovation Council
Key Investors in FEops
PMVenture
PMVenture is a consulting firm that provides innovative solutions across various industries, focusing on corporate training, technology solutions, and staff augmentation to foster business growth.
Capricorn Venture Partners
Capricorn Partners is an independent manager specializing in venture capital and growth capital for innovative technology companies, with a focus on digital, health, and clean technologies primarily in Europe.
PMV
PMV is an investment company dedicated to shaping Flanders' economic future by financing promising companies from inception through growth and internationalization, offering tailored financial solutions.
What's next for FEops?
With its latest round of major strategic investment, FEops is poised for accelerated growth and further development of its innovative digital tools for cardiology. The company's trajectory, marked by consistent funding rounds from Series A through Series B and now a significant debt financing, indicates a strong market validation and a clear path toward scaling its operations. This capital infusion is expected to fuel product enhancement, market expansion, and the strengthening of strategic partnerships, solidifying FEops' position as a leader in digital health solutions for cardiovascular diseases.
See full FEops company page
